Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Phoenix › NPI 1700823051
Physician

Retinal Consultants of Arizona LTD

Retinal Consultants of Arizona LTD was paid $6.16M by Medicaid between Jan 2018 and Dec 2024, across 20 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 27% of everything it billed.

33Billing provider infoRETINAL CONSULTANTS OF ARIZONA LTD
PHOENIX, AZ 85014
33aNPI1700823051assigned 06/02/2006
33bProvider typeOphthalmology Physician
28Total paid$6.16M
24GClaims96,727
24DCodes billed20
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ophthalmology Physician providers in Arizona

Rank by total paid#7 of 78
Median peer was paid$44K
This provider vs. median141×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BROOKFIELD, ARTHUR controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812,250$382K
201911,778$460K
202010,973$481K
202116,467$956K
202217,463$1.27M
202317,135$1.59M
2024incomplete10,661$1.03M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
67028 Intravitreal injection of a pharmacologic agent 27% 24,565 22,443 $1.65M
J0178 Injection, aflibercept, 1 mg 16% 810 755 $981K
92134 14% 36,584 34,193 $862K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 11% 8,151 7,740 $677K
J7999 Compounded drug, not otherwise classified 8.1% 8,229 7,053 $500K
J2778 Injection, ranibizumab, 0.1 mg 5.4% 420 393 $330K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 3.9% 4,086 3,683 $241K
J9035 Injection, bevacizumab, 10 mg 3.6% 3,401 3,086 $219K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.7% 4,022 3,677 $165K
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg 2.2% 308 301 $134K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.5% 1,312 1,205 $89K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 1.3% 556 548 $77K
8 more codes
67210 <1% 190 $55K
99213 Doctor's office visit, returning patient (routine) <1% 2,203 $52K
92235 <1% 614 $45K
J2777 Injection, faricimab-svoa, 0.1 mg <1% 33 $44K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 344 $15K
92250 <1% 538 $14K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 262 $6K
99203 Doctor's office visit, new patient (routine) <1% 99 $5K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROOKFIELD, ARTHUR (CFO)
Same official

Other billing entities under BROOKFIELD, ARTHUR

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.